The China Mail - US panel weighs authorizing Covid vaccines for youngest children

USD -
AED 3.672504
AFN 66.344071
ALL 83.58702
AMD 382.869053
ANG 1.789982
AOA 917.000367
ARS 1417.025504
AUD 1.541925
AWG 1.805
AZN 1.70397
BAM 1.691481
BBD 2.013336
BDT 122.007014
BGN 1.688704
BHD 0.37702
BIF 2943.839757
BMD 1
BND 1.3018
BOB 6.91701
BRL 5.339104
BSD 0.999615
BTN 88.59887
BWP 13.420625
BYN 3.406804
BYR 19600
BZD 2.010326
CAD 1.405304
CDF 2150.000362
CHF 0.803804
CLF 0.024059
CLP 943.820396
CNY 7.11935
CNH 7.12516
COP 3783.01
CRC 501.883251
CUC 1
CUP 26.5
CVE 95.363087
CZK 20.98704
DJF 177.720393
DKK 6.44754
DOP 64.223754
DZD 130.42404
EGP 47.35604
ERN 15
ETB 154.306137
EUR 0.86341
FJD 2.28475
FKP 0.763092
GBP 0.75908
GEL 2.70504
GGP 0.763092
GHS 10.930743
GIP 0.763092
GMD 73.000355
GNF 8677.076622
GTQ 7.659909
GYD 209.133877
HKD 7.777204
HNL 26.282902
HRK 6.505904
HTG 133.048509
HUF 331.923504
IDR 16697
ILS 3.26205
IMP 0.763092
INR 88.68535
IQD 1309.474904
IRR 42100.000352
ISK 126.403814
JEP 0.763092
JMD 160.439
JOD 0.70904
JPY 153.06904
KES 129.203801
KGS 87.450384
KHR 4023.264362
KMF 421.00035
KPW 899.97951
KRW 1458.910383
KWD 0.30681
KYD 0.83302
KZT 524.767675
LAK 21703.220673
LBP 89512.834262
LKR 304.684561
LRD 182.526573
LSL 17.315523
LTL 2.95274
LVL 0.60489
LYD 5.458091
MAD 9.265955
MDL 17.042585
MGA 4492.856402
MKD 53.206947
MMK 2099.259581
MNT 3583.067197
MOP 8.007472
MRU 39.595594
MUR 45.910378
MVR 15.405039
MWK 1733.369658
MXN 18.475075
MYR 4.176039
MZN 63.950377
NAD 17.315148
NGN 1436.660377
NIO 36.782862
NOK 10.14901
NPR 141.758018
NZD 1.77798
OMR 0.384498
PAB 0.999671
PEN 3.37342
PGK 4.220486
PHP 59.020375
PKR 282.656184
PLN 3.661775
PYG 7072.77311
QAR 3.643196
RON 4.392904
RSD 101.210373
RUB 80.950017
RWF 1452.42265
SAR 3.750507
SBD 8.230592
SCR 13.652393
SDG 600.503676
SEK 9.520604
SGD 1.30096
SHP 0.750259
SLE 23.203667
SLL 20969.499529
SOS 571.228422
SRD 38.599038
STD 20697.981008
STN 21.189281
SVC 8.746265
SYP 11055.784093
SZL 17.321588
THB 32.403646
TJS 9.226139
TMT 3.51
TND 2.954772
TOP 2.342104
TRY 42.210404
TTD 6.77604
TWD 30.983504
TZS 2455.000335
UAH 41.915651
UGX 3498.408635
UYU 39.809213
UZS 12055.19496
VES 228.194038
VND 26310
VUV 122.098254
WST 2.816104
XAF 567.301896
XAG 0.020707
XAU 0.00025
XCD 2.70255
XCG 1.801521
XDR 0.707015
XOF 567.306803
XPF 103.14423
YER 238.503589
ZAR 17.29989
ZMK 9001.203584
ZMW 22.615629
ZWL 321.999592
  • RBGPF

    0.0000

    76

    0%

  • BP

    0.6950

    36.515

    +1.9%

  • CMSC

    0.0000

    23.78

    0%

  • AZN

    0.7700

    84.54

    +0.91%

  • NGG

    1.6000

    77.89

    +2.05%

  • RIO

    0.0650

    69.335

    +0.09%

  • SCS

    -0.0300

    15.73

    -0.19%

  • GSK

    -0.5300

    46.57

    -1.14%

  • BTI

    0.3850

    54.595

    +0.71%

  • CMSD

    0.1290

    24.139

    +0.53%

  • JRI

    -0.0700

    13.68

    -0.51%

  • RYCEF

    -0.1800

    14.82

    -1.21%

  • RELX

    -1.1500

    42.24

    -2.72%

  • BCC

    -0.3200

    70.41

    -0.45%

  • VOD

    0.2300

    11.57

    +1.99%

  • BCE

    -0.0150

    23.155

    -0.06%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: © AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

C.Smith--ThChM